Nelfinavir Inhibits the TCF11/Nrf1-Mediated Proteasome Recovery Pathway in Multiple Myeloma.

Fassmannová, Dominika; Sedlák, Frantisek; Sedlácek, Jindrich; Spicka, Ivan; Grantz Sasková, Klára

Fassmannová, Dominika; Sedlák, Frantisek; Sedlácek, Jindrich; Spicka, Ivan; Grantz Sasková, Klára.

Afiliação

Fassmannová D; Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo n. 2, 16610 Prague, Czech Republic.
Sedlák F; Department of Genetics and Microbiology, Charles University, Vinicná 5, 12843 Prague, Czech Republic.
Sedlácek J; First Faculty of Medicine, Charles University, Katerinská 32, 12108 Prague, Czech Republic.
Spicka I; Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo n. 2, 16610 Prague, Czech Republic.
Grantz Sasková K; Department of Genetics and Microbiology, Charles University, Vinicná 5, 12843 Prague, Czech Republic.

Cancers (Basel) ; 12(5)2020 Apr 25.

Article em En | MEDLINE | ID: mdl-32344880

Palavras-chave

DDI2; TCF11/Nrf1; bortezomib; carfilzomib; multiple myeloma; nelfinavir; proteasome; proteasome inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: República Tcheca

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google